Sales & Marketing News | pharmaphorum

News

TrumpRx, BlinkRX, GoodRx – what's going on in DTC sales?

Possible implications of TrumpRx, the federal direct-to-consumer sales channel, are starting to emerge ahead of its scheduled launch next year.

News

Pharmacist shelving medicine in pharmacy

NHS could pay more for medicines under new plan

Changes to the threshold used by NICE to measure cost-effectiveness could be on the way as part of a plan that would raise NHS spending on medicines.

News

Regeneron's Libtayo stakes out new territory in skin cancer

Regeneron's Libtayo has become the first checkpoint inhibitor to be cleared by the FDA as an adjuvant treatment for cutaneous squamous cell carcinoma.

News

Image of J&J baby powder as originally sold

J&J on the hook for $966m damages in latest talc lawsuit

Johnson & Johnson has suffered a setback in its long-running legal defence against claims its talc products cause cancer.

News

Boehringer bags FDA okay for new pulmonary fibrosis drug

Boehringer's successor to blockbuster IPF therapy Ofev has been approved by the FDA as Jascayd, but will the new drug be a commercial success?

News

Pills piled together in the shape of the USA

FDA pilots fast-track scheme for US-made generics

In another effort to boost domestic drug manufacturing, the FDA is piloting fast-track reviews for generics tested and made in US facilities.

TrumpRx, BlinkRX, GoodRx – what's going on in DTC sales?

NHS could pay more for medicines under new plan

Regeneron's Libtayo stakes out new territory in skin cancer

J&J on the hook for $966m damages in latest talc lawsuit

Boehringer bags FDA okay for new pulmonary fibrosis drug

FDA pilots fast-track scheme for US-made generics

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

News

Editor's Picks